With 18.34% Distance From Low, Could Legend Biotech Corp ADR (NASDAQ:LEGN) Post Further Gains?

EVTL

In last trading session, Legend Biotech Corp ADR (NASDAQ:LEGN) saw 1.23 million shares changing hands with its beta currently measuring 0.15. Company’s recent per share price level of $33.48 trading at $0.05 or 0.15% at ring of the bell on the day assigns it a market valuation of $6.16B. That closing price of LEGN’s stock is at a discount of -81.81% from its 52-week high price of $60.87 and is indicating a premium of 18.34% from its 52-week low price of $27.34. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.88 million shares which gives us an average trading volume of 1.79 million if we extend that period to 3-months.

For Legend Biotech Corp ADR (LEGN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.19. Splitting up the data highlights that, out of 11 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 11 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Legend Biotech Corp ADR (NASDAQ:LEGN) trade information

Upright in the green during last session for gaining 0.15%, in the last five days LEGN remained trading in the red while hitting it’s week-highest on Tuesday, 06/24/25 when the stock touched $33.48 price level, adding 4.53% to its value on the day. Legend Biotech Corp ADR’s shares saw a change of -22.30% in year-to-date performance and have moved -4.04% in past 5-day. Legend Biotech Corp ADR (NASDAQ:LEGN) showed a performance of 16.41% in past 30-days. Number of shares sold short was 14.37 million shares which calculate 6.39 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 75 to the stock, which implies a rise of 55.36% to its current value. Analysts have been projecting 75 as a low price target for the stock while placing it at a high target of 75. It follows that stock’s current price would drop -124.01% in reaching the projected high whereas dropping to the targeted low would mean a loss of -124.01% for stock’s current value.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 0.79% during past 5 years.

Legend Biotech Corp ADR (NASDAQ:LEGN)’s Major holders

Insiders are in possession of 1.33% of company’s total shares while institution are holding 47.77 percent of that, with stock having share float percentage of 48.42%. Investors also watch the number of corporate investors in a company very closely, which is 47.77% institutions for Legend Biotech Corp ADR that are currently holding shares of the company. FMR LLC is the top institutional holder at LEGN for having 17.62 million shares of worth $780.46 million. And as of 2024-06-30, it was holding 9.6503 of the company’s outstanding shares.

The second largest institutional holder is PRICE T ROWE ASSOCIATES INC /MD/, which was holding about 11.49 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.292 of outstanding shares, having a total worth of $508.86 million.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.